No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
LFST LifeStance Health
- 6.150
- -0.020-0.32%
Trading Apr 25 15:15 ET
2.35BMarket Cap-12058P/E (TTM)
6.151High6.010Low528.37KVolume6.090Open6.170Pre Close3.21MTurnover0.60%Turnover RatioLossP/E (Static)382.24MShares9.59052wk High1.65P/B540.87MFloat Cap4.73552wk Low--Dividend TTM87.95MShs Float29.811Historical High--Div YieldTTM2.29%Amplitude4.220Historical Low6.080Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Morgan Stanley Reiterates Overweight on LifeStance Health Gr, Maintains $10 Price Target
Analysts Are Bullish on These Healthcare Stocks: Lifestance Health Group (LFST), LifeMD (LFMD)
LifeStance to Host First Quarter 2024 Earnings Conference Call on May 9, 2024
SCOTTSDALE, Ariz., April 18, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter 2024 earnings
14 Companies With a Near-term Catalyst Around 1Q Earnings - MS
Calculating The Intrinsic Value Of LifeStance Health Group, Inc. (NASDAQ:LFST)
Key Insights Using the 2 Stage Free Cash Flow to Equity, LifeStance Health Group fair value estimate is US$6.61 LifeStance Health Group's US$6.05 share price indicates it is trading at similar level
Lifeist Reports Highest Quarterly Gross Profit In History, Continues To Diversify Its Wellness Business
Lifeist Wellness Inc. (TSXV:LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF) reported its financial results Monday for the three and 12 months ended Nov. 30, 2023.The Toronto-based company noted it had achieve
Comments
LifeStance Health Group's positive outlook appears to be priced in, but its high growth potential at a fair price makes it an attractive investment. Higher cash flow is expected, potentially leading to a higher share valuation.
Is LifeStance Health Group, Inc. (NASDAQ:LFST) Potentially Undervalued? 1
LifeStance's CEO, Ken Burdick, is confident that Dr. DeLuca's skills will complement the board as they expand mental healthcare access. Dr. DeLuca is excited to join and help more patients receive personalized care.
1
LifeStance Health Group's high P/S ratio reflects market expectations of continued strong revenue growth. Investors may overpay if these expectations aren't met, but strong future revenue forecasts suggest a decrease in revenues is unlikely.
Despite top line growth, LifeStance Health Group is incurring a loss of US$145m on the EBIT line. The company's balance sheet, burdened with liabilities against cash, is deemed unfit and risky.
1
CEO Ken Burdick is confident in Dr. Ramtekkar's ability to drive exceptional patient and clinical outcomes, citing his commitment to clinical excellence. Dr. Ramtekkar is excited to join LifeStance and continue setting the bar for clinical excellence in mental health.
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg